NASDAQ
Day One Biopharmaceuticals, Inc. (DAWN) has a fcf yield of -10.80% as of Friday, May 29, 2026. This represents a 31.45% decrease compared to its 12-month average of -8.22%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.